Liquid Biopsy Applications and Challenges

A special issue of BioTech (ISSN 2673-6284). This special issue belongs to the section "Medical Biotechnology".

Deadline for manuscript submissions: closed (20 March 2024) | Viewed by 274

Special Issue Editor


E-Mail Website
Guest Editor
Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science & UCLA School of Medicine, Los Angeles, CA, USA
Interests: liquid biopsy; precision medicine; regenerative medicine; stem cells; drug discovery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Liquid biopsy is not literally a biopsy, but is a new diagnostic concept applied to optimize the management and follow up for cancer patients by using circulating tumor cells (CTC), cell free DNA (cfDNA), cell free RNA (cfRNA) and micro-RAN (miRNA) that are released from primary tumor or metastatic deposits into the peripheral blood or body fluids.

Liquid biopsy is not an invasive procedure, and it aims to detect target molecules, monitor therapeutic response and resistance, avoid repeat tissue biopsies where the tissue is not available and predict prognosis. Hence, liquid biopsy has become the leading molecular technique for precision medicine.

Several techniques are used to conduct this test, including PCR-based detection techniques, next generation sequencing (NGS)-based detection techniques and immunological antibodies for receptors on the surface of CTC.

On the other hand, a series of clinical validations are needed before we can adopt this technique for diagnostic purposes. 

In fact, the applications of liquid biopsy go beyond the field of oncology, such as in the fields of obstetrics, cardiology and pediatrics.

Dr. John Yahya I. Elshimali
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. BioTech is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • indications of liquid biopsy
  • sources of samples
  • liquid biopsy techniques
  • application of liquid biopsy in malignancies
  • application of liquid biopsies on other diseases
  • limitations of liquid biopsies
  • optimizing of liquid biopsy application

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop